| Name | Clover Biopharmaceuticals, Ltd. |
|---|---|
| CIK | 0001856491 |
| Tickers | CBPHF |
| Exchanges | OTC |
| Entity type | other |
| Category | — |
| SIC | — |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | E9 Cayman Islands |
| Phone | 0086-28-8533-6966 |
| Website | — |
| Investor website | — |
| Owner org | — |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
6 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | D | xslFormDX01/primary_doc.xml | 06b | 0001856491-26-000003 | 021-582300 | 26916439 | 33 | 7944 | ||
| 2025-04-28 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001856491-25-000001 | 021-510412 | 25879088 | 33 | 7982 | ||
| 2024-04-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001856491-24-000005 | 021-510412 | 24839850 | 33 | 7877 | ||
| 2023-05-09 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001104659-23-057396 | 021-397534 | 23899756 | 33 | 7683 | ||
| 2022-05-24 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001104659-22-064094 | 021-397534 | 22953977 | 33 | 7837 | ||
| 2021-04-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001104659-21-056432 | 021-397534 | 21863429 | 33 | 9861 |
SEC 404 https://data.sec.gov/api/xbrl/companyfacts/CIK0001856491.json
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No XBRL companyfacts for this CIK. | |||||||||||